BioInvent International Stock

BioInvent International Interest Coverage

The Interest Coverage Ratio of BioInvent International (BINV.ST) as of Aug 4, 2026 is -18.28. In the previous year, Interest Coverage Ratio was -11.21 — a change of 63.01% (lower).

Interest Coverage

-18.28

YoY

63.01%

Last updated:

Interest Coverage Ratio of BioInvent International is 2026 -18.28 . Interest Coverage Ratio of BioInvent International was 2025 -11.21 . It decreases by 63.01% lower compared to the previous year.
Access this data via the Eulerpool API

BioInvent International Stock analysis

What does BioInvent International do? BioInvent International AB is a Swedish biopharmaceutical company specializing in the discovery and development of therapeutic antibodies. It was founded in 1986 and is headquartered in Lund, Sweden. BioInvent conducts research and development activities in the fields of immuno-oncology, inflammatory diseases, and fibrosis. BioInvent International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioInvent International stock

Interest Coverage Ratio of BioInvent International is -18.28 in 2026.

Interest Coverage Ratio of BioInvent International changed from -11.21 to -18.28, representing a 63.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio BioInvent International since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's BioInvent International with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — BioInvent International

All Key Metrics — BioInvent International